Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Avastin for central retinal vein occlusion
2008-006265-93Phase 2Active
- Sponsor
- St. Eriks Eye Hospital
- Start
- Oct 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in central retinal vein occlusion (CRVO) comparing Intravitreal Avastin with Observation / natural course (2 arms). Primary endpoint: Visual acuity response at 6 months. Started Oct 2008; status: active.
02
Drugs
bevacizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2008-006265-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006265-93.